Pharmaceutical News

RSS

MGI empowers life cienss industry with revolutionary what if campaign at XXIIIrd International Congress of Genetics

MGI Tech Co. Ltd. (MGI), a company committed to building core tools and technology to lead life science, today announced the launch of a global brand campaign titled “What If?” at the XXIII International Congress of Genetics (ICG), a five-yearly conference to bring together the international genetics community from around the world.

From MGI 17 Jul 2023

NIH funding for phased clinical trials represents <3.5% of total spending

The U.S. National Institutes of Health (NIH) contributed $8.1 billion in project funding for phased clinical trials involving drugs approved by the FDA from 2010-2019, according to a new study from Bentley University's Center for Integration of Science and Industry.

14 Jul 2023

C-Path and Vivpro join forces to advance drug development

Critical Path Institute, a leading global nonprofit committed to expediting drug development through the acceleration of regulatory-endorsed solutions, today announced a newly formalized Memorandum of Understanding with Vivpro, an industry-leading provider of a revolutionary biointelligence software platform and innovative services.

13 Jul 2023

Pharmacist-led intervention can help suppress multi-drug resistant pathogens

The battle to stop the increase of superbugs in hospitals has been an ongoing struggle for healthcare professionals.

13 Jul 2023

Wait, What’s a PBM?

Pharmacy benefit managers, or PBMs, are intermediary companies that negotiate the price of prescription drugs.

13 Jul 2023

Lecanemab: First disease-modifying therapy for Alzheimer's disease approved by FDA

On July 6, 2023, the U.S. Food and Drug Administration granted full approval to lecanemab, marketed as Leqembi, for the treatment of Alzheimer's disease.

12 Jul 2023

Older age and certain health conditions increase risk of COVID-19 death in boosted individuals

Researchers identify patient groups at a higher risk of death due to COVID-19 among adults who received a second booster dose in England.

12 Jul 2023

Rethinking how cancer immunotherapy drugs are delivered could save millions

A new analysis finds that up to millions of dollars could be saved annually on cancer immunotherapy treatments across the Veterans Health Administration by reconsidering how those drugs are delivered.

11 Jul 2023

THC-O-acetate's psychedelic effects may be greatly exaggerated

The cannabis plant is complex, with about 100 cannabinoids, or compounds, many of which science still knows little or nothing about.

11 Jul 2023

Gift of $1.5 million will fund DMT research at UC San Diego

One of the most powerful psychedelics known, N,N-dimethyltryptamine (DMT) has been described as causing imaginative visuals akin to the dream state.

11 Jul 2023

Prescription stimulants safe for treating ADHD, study finds

Many parents whose kids take prescription stimulants like Ritalin to treat ADHD worry that it could lead to illicit drug use later.

11 Jul 2023

Novel vaccine against Lyme disease reported to be safe and effective

Researchers determine the safety and immunogenicity of a novel candidate vaccine against Lyme borreliosis.

11 Jul 2023

The American Journal of Health Economics articles examine policies to address opioid crisis

The August 2023 issue of the American Journal of Health Economics will feature a cluster of articles that examine the opioid crisis.

10 Jul 2023

New drug shows synergistic effect with antifungals in killing drug-resistant fungi

A study conducted at the University of São Paulo (USP) in Brazil shows that brilacidin, a new drug tested for treatment of diseases ranging from bacterial skin infections to COVID-19, can kill drug-resistant strains of fungi when combined with two classes of antifungals available on the market.

10 Jul 2023

AMP releases consensus recommendations for CYP3A4 and CYP3A5 genotyping assays

The Association for Molecular Pathology (AMP), the premier global molecular diagnostic professional society, today published consensus recommendations to aid in the design and validation of clinical CYP3A4 and CYP3A5 genotyping assays, promote standardization of testing across different laboratories, and improve patient care.

10 Jul 2023

What you need to know about the drug price fight in those TV ads

In recent months ominous ads about prescription drugs have flooded the TV airwaves. Perhaps by design, it's not always clear who's sponsoring the ads or why.

10 Jul 2023

Lilly granted MHRA marketing authorization in Great Britain for a ground-breaking UC therapy

Eli Lilly and Company announced today that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation (MA) for mirikizumab (OMVOH®) for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic treatment.

10 Jul 2023

Moderna provides an update on regulatory submissions for RSV vaccine candidate, mRNA-1345

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today provided an update on regulatory submissions for mRNA-1345, a vaccine for the prevention of RSV-associated lower respiratory tract disease (RSV-LRTD) and acute respiratory disease (ARD) in adults aged 60 years or older.

10 Jul 2023

Unique plant extract mixture has potent anti-acne effects

Researchers evaluate the efficacy of FRO, a formula composed of fermented Rhus verniciflua Stokes and Orostachys japonicus, against acne pathogenesis via antimicrobial assessment and an in vitro analysis. FRO was found to contain phenolics such as gallic acid, fisetin, quercetin, and kaempferol and was determined to alleviate acne by inhibiting the growth of Cutibacterium acnes, inflammation, and excess sebum.

9 Jul 2023

COVID-19 strikes harder on low-income communities in LA; Vaccination proves key to reducing disparity

COVID-19 incidence rates were higher in lower-income communities compared to higher-income communities before vaccines became available in Los Angeles. However, after vaccination, the disparity in COVID-19 incidence diminished, with the lowest-income communities experiencing the highest impact of vaccination.

5 Jul 2023

Previous
1
...
55
56
57
58
59
60
61
...
1443
Next

Pharmaceutical News

MGI empowers life cienss industry with revolutionary what if campaign at XXIIIrd International Congress of Genetics

NIH funding for phased clinical trials represents <3.5% of total spending

C-Path and Vivpro join forces to advance drug development

Pharmacist-led intervention can help suppress multi-drug resistant pathogens

Wait, What’s a PBM?

Lecanemab: First disease-modifying therapy for Alzheimer's disease approved by FDA

Older age and certain health conditions increase risk of COVID-19 death in boosted individuals

Rethinking how cancer immunotherapy drugs are delivered could save millions

THC-O-acetate's psychedelic effects may be greatly exaggerated

Gift of $1.5 million will fund DMT research at UC San Diego

Prescription stimulants safe for treating ADHD, study finds

Novel vaccine against Lyme disease reported to be safe and effective

The American Journal of Health Economics articles examine policies to address opioid crisis

New drug shows synergistic effect with antifungals in killing drug-resistant fungi

AMP releases consensus recommendations for CYP3A4 and CYP3A5 genotyping assays

What you need to know about the drug price fight in those TV ads

Lilly granted MHRA marketing authorization in Great Britain for a ground-breaking UC therapy

Moderna provides an update on regulatory submissions for RSV vaccine candidate, mRNA-1345

Unique plant extract mixture has potent anti-acne effects

COVID-19 strikes harder on low-income communities in LA; Vaccination proves key to reducing disparity

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Latest News